UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 153

Sortiert nach

Role of the Pruritic Cytokine IL-31 in Autoimmune Skin Diseases

Frontiers in immunology, 2019-06, Vol.10, p.1383-1383

2019

Volltextzugriff (PDF)

Molecular targets on mast cells and basophils for novel therapies

Journal of allergy and clinical immunology, 2014-09, Vol.134 (3), p.530-544

2014

Volltextzugriff (PDF)

Basophils, high-affinity IgE receptors, and CCL2 in human anaphylaxis

Journal of allergy and clinical immunology, 2017-09, Vol.140 (3), p.750-758.e15

2017

Volltextzugriff (PDF)

Siglec-7 is an inhibitory receptor on human mast cells and basophils

Journal of allergy and clinical immunology, 2014-07, Vol.134 (1), p.230-233.e3

2014

Volltextzugriff (PDF)

The Tim-3-Galectin-9 Pathway and Its Regulatory Mechanisms in Human Breast Cancer

Frontiers in immunology, 2019-07, Vol.10, p.1594-1594

2019

Volltextzugriff (PDF)

IgE-dependent human basophil responses are inversely associated with the sarcoplasmic reticulum Ca2+-ATPase (SERCA)

Frontiers in immunology, 2023-01, Vol.13, p.1052290-1052290

2023

Volltextzugriff (PDF)

Ligand-Receptor Interactions of Galectin-9 and VISTA Suppress Human T Lymphocyte Cytotoxic Activity

Frontiers in immunology, 2020-11, Vol.11, p.580557-580557

2020

Volltextzugriff (PDF)

The Tim-3-galectin-9 Secretory Pathway is Involved in the Immune Escape of Human Acute Myeloid Leukemia Cells

EBioMedicine, 2017-08, Vol.22 (C), p.44-57

2017

Volltextzugriff (PDF)

L-Kynurenine participates in cancer immune evasion by downregulating hypoxic signaling in T lymphocytes

Oncoimmunology, 2023-12, Vol.12 (1), p.2244330-2244330

2023

Volltextzugriff (PDF)

Eosinophils are a Major Source of Interleukin-31 in Bullous Pemphigoid

Acta dermato-venereologica, 2018, Vol.98 (8), p.766-771

2018

Volltextzugriff (PDF)

Macrophage Differentiation and Polarization Regulate the Release of the Immune Checkpoint Protein V-Domain Ig Suppressor of T Cell Activation

Frontiers in immunology, 2022-05, Vol.13, p.837097-837097

2022

Volltextzugriff (PDF)

Differential expression and biochemical activity of the immune receptor Tim-3 in healthy and malignant human myeloid cells

Oncotarget, 2015-10, Vol.6 (32), p.33823-33833

2015

Volltextzugriff (PDF)

Nanoparticle-based immunotherapy of pancreatic cancer

Frontiers in molecular biosciences, 2022-08, Vol.9, p.948898-948898

2022

Volltextzugriff (PDF)

Endocannabinoids limit excessive mast cell maturation and activation in human skin

Journal of allergy and clinical immunology, 2012-03, Vol.129 (3), p.726-738.e8

2012

Volltextzugriff (PDF)

High Mobility Group Box 1 (HMGB1) Induces Toll-Like Receptor 4-Mediated Production of the Immunosuppressive Protein Galectin-9 in Human Cancer Cells

Frontiers in immunology, 2021-06, Vol.12, p.675731-675731

2021

Volltextzugriff (PDF)

T lymphocytes induce human cancer cells derived from solid malignant tumors to secrete galectin-9 which facilitates immunosuppression in cooperation with other immune checkpoint proteins

Journal for immunotherapy of cancer, 2023-01, Vol.11 (1), p.e005714

2023

Volltextzugriff (PDF)

Human mast cells and basophils—How are they similar how are they different?

Immunological reviews, 2018-03, Vol.282 (1), p.8-34

2018

Volltextzugriff (PDF)

SHIP1 and the negative control of mast cell/basophil activation by supra-optimal antigen concentrations

Molecular immunology, 2015-01, Vol.63 (1), p.32-37

2015

Volltextzugriff (PDF)

The immune receptor Tim-3 acts as a trafficker in a Tim-3/galectin-9 autocrine loop in human myeloid leukemia cells

Oncoimmunology, 2016-07, Vol.5 (7), p.e1195535-e1195535

2016

Volltextzugriff (PDF)

Editorial: Pathological reactions of cytotoxic lymphoid cells as universal therapeutic targets in cancer and autoimmune disease

Frontiers in medicine, 2023, Vol.10, p.1186318-1186318

2023

Volltextzugriff (PDF)

Involvement of hypoxia-inducible factor-1 in the inflammatory responses of human LAD2 mast cells and basophils

PloS one, 2012-03, Vol.7 (3), p.e34259-e34259

2012

Volltextzugriff (PDF)

Early-life risk factors which govern pro-allergic immunity

Seminars in immunopathology, 2024-08, Vol.46 (3-4), p.9, Article 9

2024

Volltextzugriff (PDF)

High mobility group box 1 (HMGB1) acts as an "alarmin" to promote acute myeloid leukaemia progression

Oncoimmunology, 2018-06, Vol.7 (6), p.e1438109-e1438109

2018

Volltextzugriff (PDF)

Interleukin-1 beta induces the expression and production of stem cell factor by epithelial cells： crucial involvement of the PI-3K/mTOR pathway and HIF-1 transcription complex

Cellular & molecular immunology, 2016-01, Vol.13 (1), p.47-56

2016

Volltextzugriff (PDF)

Mast Cells as Drivers of Disease and Therapeutic Targets

Trends in immunology, 2018-02, Vol.39 (2), p.151-162

2018

Volltextzugriff (PDF)

1 – 25 von 153

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(97)
Mit Volltextzugriff
(106)

Publikationsform

Artikel
(150)
Buchkapitel
(3)

Sprache

Englisch
(152)
Japanisch
(27)
Deutsch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Role of the Pruritic Cytokine IL-31 in Autoimmune Skin Diseases

Molecular targets on mast cells and basophils for novel therapies

Basophils, high-affinity IgE receptors, and CCL2 in human anaphylaxis

Siglec-7 is an inhibitory receptor on human mast cells and basophils

The Tim-3-Galectin-9 Pathway and Its Regulatory Mechanisms in Human Breast Cancer

IgE-dependent human basophil responses are inversely associated with the sarcoplasmic reticulum Ca2+-ATPase (SERCA)

Ligand-Receptor Interactions of Galectin-9 and VISTA Suppress Human T Lymphocyte Cytotoxic Activity

The Tim-3-galectin-9 Secretory Pathway is Involved in the Immune Escape of Human Acute Myeloid Leukemia Cells

L-Kynurenine participates in cancer immune evasion by downregulating hypoxic signaling in T lymphocytes

Eosinophils are a Major Source of Interleukin-31 in Bullous Pemphigoid

Macrophage Differentiation and Polarization Regulate the Release of the Immune Checkpoint Protein V-Domain Ig Suppressor of T Cell Activation

Differential expression and biochemical activity of the immune receptor Tim-3 in healthy and malignant human myeloid cells

Nanoparticle-based immunotherapy of pancreatic cancer

Endocannabinoids limit excessive mast cell maturation and activation in human skin

High Mobility Group Box 1 (HMGB1) Induces Toll-Like Receptor 4-Mediated Production of the Immunosuppressive Protein Galectin-9 in Human Cancer Cells

T lymphocytes induce human cancer cells derived from solid malignant tumors to secrete galectin-9 which facilitates immunosuppression in cooperation with other immune checkpoint proteins

Human mast cells and basophils—How are they similar how are they different?

SHIP1 and the negative control of mast cell/basophil activation by supra-optimal antigen concentrations

The immune receptor Tim-3 acts as a trafficker in a Tim-3/galectin-9 autocrine loop in human myeloid leukemia cells

Editorial: Pathological reactions of cytotoxic lymphoid cells as universal therapeutic targets in cancer and autoimmune disease

Involvement of hypoxia-inducible factor-1 in the inflammatory responses of human LAD2 mast cells and basophils

Early-life risk factors which govern pro-allergic immunity

High mobility group box 1 (HMGB1) acts as an "alarmin" to promote acute myeloid leukaemia progression

Interleukin-1 beta induces the expression and production of stem cell factor by epithelial cells： crucial involvement of the PI-3K/mTOR pathway and HIF-1 transcription complex

Mast Cells as Drivers of Disease and Therapeutic Targets

Suchergebnisse filtern